부광약품
ABOUT BUKWANG
Company Introduction
Vision & Mission
History
Manufacturing Facilities
Subsidiaries & Affiliates
Contact us
R&D
R&D Facilities
Pipeline
Latuda
JM-010
CP-012
Open Innovation
NEWS
IR
Financial Information
IR Reports
ANNUAL REPORT
PRODUCTS
Product Search
ETC
OTC
Health Functional Food
Personal Care Products
HOME
CONTACT US
KR
KR
EN
ABOUT BUKWANG
Company Introduction
Vision & Mission
History
Manufacturing Facilities
Subsidiaries & Affiliates
Contact us
R&D
R&D Facilities
Pipeline
Latuda
JM-010
CP-012
Open Innovation
JaguAhr
Protekt
NEWS
News
IR
Financial Information
IR Reports
ANNUAL REPORT
PRODUCTS
Product Search
ETC
OTC
Health Functional Food
Personal Care Products
NEWS
HOME
NEWS
NEWS
NEWS
ALL
Company news
Product news
R&D news
Company news | Contera Pharma, subsidiary of Bukwang, raised 51 billion KRW..
Contera Pharma (“Contera”), subsidiary of Bukwang Pharmaceutical (“Bukwang”), an..
2020.06.30
Company news | ProteKt Therapeutics Raises $3.6 Million in Post-incubation..
ProteKt Therapeutics, a biotech company developing new PKR kinase inhibitor base..
2019.11.13
Company news | ASLAN PHARMACEUTICALS AND BUKWANG PHARMACEUTICAL ESTABLISH ..
-ASLAN spins out pre-clinical assets in joint venture with Bukwang to form JAGUA..
2019.09.30
Company news | Contera Pharma, a subsidiary of Bukwang Pharmaceutical, att..
- 3 million dollars invested by Medici Investment- European Clinical phase 2 stu..
2019.07.10
Company news | Bukwang Pharmaceutical Co., Ltd certified ISO14001 / OHSAS1..
2016, Nov 17, Bukwang received certifications of both Occupational Health and Sa..
2016.11.17
Company news | Dyna Therapeutics Co., Ltd, a newly launched project focused..
Bukwang Pharmaceutical Co., Ltd (“Bukwang”) today announces the creation of a Pr..
2016.06.30
1
2
3
4
5